Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.
about
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinomaEconomic benefits of hepatitis B vaccination at sexually transmitted disease clinics in the U.SContribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinomaNew advances in hepatocellular carcinomaHepatocellular carcinoma: Review of disease and tumor biomarkersControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaChronic viral hepatitis C: management updateSurveillance for hepatocellular carcinoma.Hepatocellular carcinoma: a reviewCirculating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinomaGuide for diagnosis and treatment of hepatocellular carcinomaImaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Current role of ultrasound for the management of hepatocellular carcinomaRecent developments in the first detection of hepatocellular carcinomaLarge variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analysesDiagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma.Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.Hepatocellular carcinoma - issues in imagingEvaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma.Proteomic analysis of extremely severe hand, foot and mouth disease infected by enterovirus 71Cancer screening in renal transplant recipients: what is the evidence?Treatment of hepatitis B in decompensated liver cirrhosis.Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma.Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.Hepatocellular carcinoma: From diagnosis to treatment.Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective studyClinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma.Future perspectives for hepatocellular carcinoma.Chronic hepatitis B infection in Canada.Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infectionSerum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.Surrogate markers of efficacy for medical treatment of viral hepatitis.Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening.Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma.Evaluation of impact of serial hepatitis B virus DNA levels on development of hepatocellular carcinoma.Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies
P2860
Q24635267-8E424FF4-4559-47E7-8476-658C9ED0635AQ24653751-577D8A4B-EEBA-4947-BEC5-2C7D53E50792Q26740332-CD5D1EB3-47A2-4256-8F3E-0249D84F3D51Q26749329-8702F1A2-46D1-4509-B9CF-4850E56BC4F6Q26750796-E88EAC39-F637-4149-969E-30E7B0EF2F38Q26772324-FB4866DD-8CA0-4D89-A25F-034D5F5743CAQ27471844-AF07BBA3-766D-4CFA-8364-4F3494ABB8BBQ27690269-7158CCE3-8B08-46E9-8976-41388DA2B664Q28069290-6BD38399-BF3D-49A0-9A11-00BF454B8672Q28080175-28689021-2EEC-48B4-A5FC-FF9721B17B29Q28084003-2A7AF00A-23D4-4A18-BEBC-785DC142053EQ30458257-BB468C55-0278-4F98-BA75-094F90E01926Q30479629-982E6434-BFBF-4A34-ADCA-7A1255864FE5Q30488974-2305E716-F2A6-48FE-8E9A-D25E6EBC7543Q34055894-674921CE-17E2-4748-97CF-70E2E14959E5Q34203972-98895793-133A-478F-B6C3-0DEE1C0A819EQ34461237-82D23043-10E5-4BE0-9DB4-C6CD643CEE4FQ34532749-2B92217C-F834-473B-ABD1-2FFDB7817E48Q34533378-DA199C19-011E-4E25-BA90-92CB0AE3D0C9Q34721561-E4EC1279-D2FC-4CBA-AA47-102A8CB47C7DQ34958589-01FB80E6-C218-4723-BF4F-8B80E25F3CEDQ35153329-A29F2E4F-9CFF-49AB-B088-4FD87336864BQ35207784-FDAA5554-E3DA-44F2-B3EB-EC952205B2B8Q35581398-96525FAC-9108-4282-811F-342886E5A418Q35596851-18D28F7F-A7FE-489F-B726-FE316D87914DQ35668716-4C4E4C33-0114-4584-B1D4-B3EA00942D48Q35777269-A4A40FCC-7164-4AFD-83A0-360748EB3C5AQ36016030-FE409F07-E7D0-4A00-BC5E-4F0F221C3D41Q36063224-0302BA58-2ED8-4D15-B66C-FF8B2F193A80Q36170444-72929CA4-A08F-44C3-8DC2-E07FAB670851Q36370370-54DEC538-B627-4E87-869C-DA68F0755D17Q36411874-B825693C-AAA0-48AF-91F0-15A76BC713FDQ36561639-E301A21E-8383-486A-A0E4-62612F240DF4Q36587304-BFE42059-86B0-42A4-8A52-6FFD8337C93FQ36724410-036D02C5-07B0-45E4-9A6E-443DEBACFC20Q36912160-14F65183-5A65-45C6-B2D0-B32BCAF691B7Q37000692-8A3BC0A7-C448-4D3A-B0EE-E548EA347F0FQ37214128-1E6E15A4-CE34-4DE8-9644-8739348B25B5Q37242795-F305A655-D220-439F-A3FA-F1CC36DFC291Q37266376-FF2F91B5-67E6-4E30-A591-63FF78F6F5F5
P2860
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Screening for hepatocellular c ...... rth American urban population.
@en
Screening for hepatocellular c ...... rth American urban population.
@nl
type
label
Screening for hepatocellular c ...... rth American urban population.
@en
Screening for hepatocellular c ...... rth American urban population.
@nl
prefLabel
Screening for hepatocellular c ...... rth American urban population.
@en
Screening for hepatocellular c ...... rth American urban population.
@nl
P2093
P356
P1433
P1476
Screening for hepatocellular c ...... rth American urban population.
@en
P2093
P304
P356
10.1002/HEP.1840220210
P407
P577
1995-08-01T00:00:00Z